Pular para o conteúdo
Doença do desenvolvimento sexual
ORPHA:90771DOENÇA RARA
Esta doença tem causa genética. Recomendamos procurar um médico geneticista para diagnóstico, exames genéticos e aconselhamento familiar.
Sangue / imune
Também conhecida comodistúrbio do desenvolvimento sexualDSD

Uma condição presente desde o nascimento, caracterizada por alterações no desenvolvimento das características sexuais.

Em construçãohistóricoSugerir correção
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

💬
EM LINGUAGEM SIMPLES

A síndrome de excesso de aromatase é uma condição caracterizada por níveis elevados do hormônio sexual feminino estrogênio tanto em homens quanto em mulheres. Homens com síndrome de excesso de aromatase apresentam aumento das mamas (ginecomastia) no final da infância ou na adolescência. Os ossos dos homens afetados crescem e se desenvolvem mais rapidamente e param de crescer mais cedo do que o usual (idade óssea avançada). Como resultado, os homens têm um surto de crescimento precoce, tipicamente durante o final da infância, com baixa estatura na idade adulta. As mulheres afetadas raramente apresentam sinais e sintomas da condição, mas podem ter aumento do crescimento das mamas (macromastia), períodos menstruais irregulares e baixa estatura. A capacidade de ter filhos (fertilidade) costuma ser normal tanto em homens quanto em mulheres com síndrome de excesso de aromatase.

Fonte: MedlinePlus Genetics (NLM/NIH), traduzido
📋
Informacoes curadas por IA — podem conter imprecisoes

Uma condição presente desde o nascimento, caracterizada por alterações no desenvolvimento das características sexuais.

Pesquisas ativas
6 ensaios
30 total registrados no ClinicalTrials.gov
Publicações científicas
82 artigos
Último publicado: 2026 Apr 1
Medicamentos
16 com registro
ANASTROZOL, HANAZ, CERMAZ

Tem tratamento?

✓ 16 medicamentos específicos desta doença (registro ANVISA, FDA ou SUS/CEAF)
Ver detalhes, fases e interações →
ANASTROZOLHANAZCERMAZANASTROLIBBSAROTHAZYARAZABIARIMIDEXANYA
Mais 10 moléculas em estudo para esta doença.
🏥
SUS: Cobertura mínimaScore: 0%
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🦴
Ossos e articulações
51 sintomas
😀
Face
42 sintomas
🧠
Neurológico
41 sintomas
📏
Crescimento
38 sintomas
🫘
Rins
29 sintomas
❤️
Coração
27 sintomas

+ 296 sintomas em outras categorias

Características mais comuns

—
Ceratodermia palmoplantar
—
Hemorragia retal
—
Testículo ausente
—
Fístula uretrovaginal
—
Genitália externa ausente
—
Hemoglobina anormal
648sintomas
Sem dados (648)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 648 características clínicas mais associadas, ordenadas por frequência.

Ceratodermia palmoplantarPalmoplantar keratoderma
Testículo ausenteAbsent testis
Fístula uretrovaginalUrethrovaginal fistula
Genitália externa ausenteAbsent external genitalia

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico82PubMed
Últimos 10 anos79publicações
Pico202516 papers
Linha do tempo
2026Hoje · 2026🧪 2004Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

28 genes identificados com associação a esta condição.

SRD5A23-oxo-5-alpha-steroid 4-dehydrogenase 2Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Androgen biosynthesis
MECANISMO DE DOENÇA

Pseudovaginal perineoscrotal hypospadias

A form of male pseudohermaphroditism in which 46,XY males show ambiguous genitalia at birth, including perineal hypospadias and a blind perineal pouch, and develop masculinization at puberty. The name of the disorder stems from the finding of a blind-ending perineal opening resembling a vagina and a severely hypospadiac penis with the urethra opening onto the perineum.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Tecido-específico)
Próstata
25.8 TPM
Fígado
11.2 TPM
Testículo
3.7 TPM
Vagina
2.3 TPM
Cervix Endocervix
0.7 TPM
OUTRAS DOENÇAS (2)
46,XY disorder of sex development due to 5-alpha-reductase 2 deficiencyprostate cancer, hereditary
HGNC:11285UniProt:P31213
DHX37Probable ATP-dependent RNA helicase DHX37Candidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (2)
rRNA modification in the nucleus and cytosolMajor pathway of rRNA processing in the nucleolus and cytosol
MECANISMO DE DOENÇA

Neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies

An autosomal recessive neurodevelopmental disorder characterized by severe developmental delay, impaired intellectual development, hypotonia, brain anomalies including cortical volume loss, corpus callosum dysgenesis and cerebellar hypoplasia, and variable dysmorphic features. Patients may have platyspondyly, scoliosis, and cardiac anomalies.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
34.9 TPM
Fibroblastos
19.3 TPM
Ovário
19.0 TPM
Útero
18.1 TPM
Nervo tibial
17.0 TPM
OUTRAS DOENÇAS (4)
neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies46,XY sex reversal 1146,XY complete gonadal dysgenesis46,XY partial gonadal dysgenesis
HGNC:17210UniProt:Q8IY37
WWOXWW domain-containing oxidoreductaseCandidate gene tested inTolerante
VIAS BIOLÓGICAS (3)
Nuclear signaling by ERBB4Activation of the TFAP2 (AP-2) family of transcription factorsNegative regulation of activity of TFAP2 (AP-2) family transcription factors
EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
13.8 TPM
Cérebro - Hemisfério cerebelar
12.1 TPM
Cerebelo
11.2 TPM
Brain Spinal cord cervical c-1
10.5 TPM
Nervo tibial
8.2 TPM
OUTRAS DOENÇAS (5)
autosomal recessive spinocerebellar ataxia 12esophageal cancerdevelopmental and epileptic encephalopathy, 28esophageal squamous cell carcinoma
HGNC:12799UniProt:Q9NZC7
SOX3Transcription factor SOX-3Candidate gene tested inModerado
VIAS BIOLÓGICAS (1)
Deactivation of the beta-catenin transactivating complex
MECANISMO DE DOENÇA

Panhypopituitarism X-linked

Affected individuals have absent infundibulum, anterior pituitary hypoplasia, and ectopic posterior pituitary.

EXPRESSÃO TECIDUAL(Tecido-específico)
Testículo
5.6 TPM
Pituitária
3.0 TPM
Hipotálamo
2.9 TPM
Brain Nucleus accumbens basal ganglia
1.6 TPM
Brain Spinal cord cervical c-1
1.4 TPM
OUTRAS DOENÇAS (7)
intellectual disability, X-linked, with panhypopituitarismpanhypopituitarism, X-linkedX-linked intellectual disability with isolated growth hormone deficiencyseptooptic dysplasia
HGNC:11199UniProt:P41225
VAMP7Vesicle-associated membrane protein 7Candidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
Clathrin-mediated endocytosis
EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
55.1 TPM
Linfócitos
52.2 TPM
Fibroblastos
50.7 TPM
Aorta
50.7 TPM
Artéria coronária
47.1 TPM
OUTRAS DOENÇAS (1)
46,XY partial gonadal dysgenesis
HGNC:11486UniProt:P51809
MTM1MyotubularinCandidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (3)
Synthesis of PIPs at the plasma membraneSynthesis of PIPs at the early endosome membraneSynthesis of PIPs at the late endosome membrane
MECANISMO DE DOENÇA

Myopathy, centronuclear, X-linked

A congenital muscle disorder characterized by progressive muscular weakness and wasting involving mainly limb girdle, trunk, and neck muscles. It may also affect distal muscles. Weakness may be present during childhood or adolescence or may not become evident until the third decade of life. Ptosis is a frequent clinical feature. The most prominent histopathologic features include high frequency of centrally located nuclei in muscle fibers not secondary to regeneration, radial arrangement of sarcoplasmic strands around the central nuclei, and predominance and hypotrophy of type 1 fibers.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
18.1 TPM
Nervo tibial
17.3 TPM
Ovário
17.1 TPM
Baço
14.4 TPM
Glândula adrenal
14.4 TPM
OUTRAS DOENÇAS (3)
X-linked myotubular myopathycentronuclear myopathyX-linked myotubular myopathy-abnormal genitalia syndrome
HGNC:7448UniProt:Q13496
MAMLD1Mastermind-like domain-containing protein 1Candidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (10)
NOTCH1 Intracellular Domain Regulates TranscriptionPre-NOTCH Transcription and TranslationNOTCH4 Intracellular Domain Regulates TranscriptionNOTCH3 Intracellular Domain Regulates TranscriptionRegulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells
MECANISMO DE DOENÇA

Hypospadias 2, X-linked

A common malformation in which the urethra opens on the ventral side of the penis, due to developmental arrest of urethral fusion. The opening can be located glandular, penile, or even more posterior in the scrotum or perineum. Hypospadias is a feature of several syndromic disorders, including the androgen insensitivity syndrome and Opitz syndrome.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
36.4 TPM
Ovário
33.9 TPM
Nervo tibial
24.9 TPM
Cervix Endocervix
17.0 TPM
Fallopian Tube
16.5 TPM
OUTRAS DOENÇAS (3)
hypospadias 2, X-linkedX-linked myotubular myopathy-abnormal genitalia syndromeposterior hypospadias
HGNC:2568UniProt:Q13495
BDNFNeurotrophic factor BDNF precursor formCandidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (10)
PI5P, PP2A and IER3 Regulate PI3K/AKT SignalingPIP3 activates AKT signalingConstitutive Signaling by Aberrant PI3K in CancerActivated NTRK2 signals through PI3KActivated NTRK2 signals through PLCG1
OUTRAS DOENÇAS (2)
WAGR syndromecentral hypoventilation syndrome, congenital, 1, with or without Hirschsprung disease
HGNC:1033UniProt:P23560
PPP2R3CSerine/threonine-protein phosphatase 2A regulatory subunit B'' subunit gammaCandidate gene tested inTolerante
MECANISMO DE DOENÇA

Myoectodermal gonadal dysgenesis syndrome

An autosomal recessive disorder characterized by 46,XY complete gonadal dysgenesis and extragonadal anomalies, including typical facial gestalt, low birth weight, myopathy, rod and cone dystrophy, anal atresia, omphalocele, sensorineural hearing loss, dry and scaly skin, skeletal abnormalities, renal agenesis and neuromotor delay.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
51.6 TPM
Linfócitos
26.8 TPM
Nervo tibial
24.4 TPM
Cervix Ectocervix
24.4 TPM
Artéria tibial
23.9 TPM
OUTRAS DOENÇAS (4)
gonadal dysgenesis, dysmorphic facies, retinal dystrophy, and myopathyspermatogenic failure 36XY type gonadal dysgenesis-associated anomalies syndromemale infertility due to globozoospermia
HGNC:17485UniProt:Q969Q6
PAX6Paired box protein Pax-6Candidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (5)
Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)Regulation of gene expression in beta cellsActivation of anterior HOX genes in hindbrain development during early embryogenesisFormation of the anterior neural plateSynthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)
MECANISMO DE DOENÇA

Aniridia 1

A congenital, bilateral, panocular disorder characterized by complete absence of the iris or extreme iris hypoplasia. Aniridia is not just an isolated defect in iris development but it is associated with macular and optic nerve hypoplasia, cataract, corneal changes, nystagmus. Visual acuity is generally low but is unrelated to the degree of iris hypoplasia. Glaucoma is a secondary problem causing additional visual loss over time.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
40.8 TPM
Cerebelo
36.9 TPM
Córtex cerebral
3.5 TPM
Brain Caudate basal ganglia
3.4 TPM
Brain Anterior cingulate cortex BA24
3.3 TPM
OUTRAS DOENÇAS (17)
coloboma, ocular, autosomal dominantisolated optic nerve hypoplasiaautosomal dominant keratitisfoveal hypoplasia 1
HGNC:8620UniProt:P26367
SRYSex-determining region Y proteinCandidate gene tested inDesconhecido
VIAS BIOLÓGICAS (2)
Deactivation of the beta-catenin transactivating complexTranscriptional regulation of testis differentiation
MECANISMO DE DOENÇA

46,XY sex reversal 1

A condition characterized by male-to-female sex reversal in the presence of a normal 46,XY karyotype. Patients manifest rapid and early degeneration of their gonads, which are present in the adult as 'streak gonads', consisting mainly of fibrous tissue and variable amounts of ovarian stroma. As a result these patients do not develop secondary sexual characteristics at puberty. The external genitalia in these subjects are completely female, and Muellerian structures are normal.

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
4.5 TPM
Skin Sun Exposed Lower leg
3.4 TPM
Skin Not Sun Exposed Suprapubic
3.1 TPM
Fibroblastos
1.6 TPM
Esôfago - Mucosa
0.8 TPM
OUTRAS DOENÇAS (6)
46,XY sex reversal 145,X/46,XY mixed gonadal dysgenesis46,XY complete gonadal dysgenesis46,XX ovotesticular disorder of sex development
HGNC:11311UniProt:Q05066
AMHR2Anti-Muellerian hormone type-2 receptorDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Signaling by BMP
MECANISMO DE DOENÇA

Persistent Muellerian duct syndrome 2

A form of male pseudohermaphroditism characterized by a failure of Muellerian duct regression in otherwise normal males.

VIAS REACTOME (1)
OUTRAS DOENÇAS (1)
persistent Mullerian duct syndrome
HGNC:465UniProt:Q16671
NR0B1Nuclear receptor subfamily 0 group B member 1Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (1)
Nuclear Receptor transcription pathway
MECANISMO DE DOENÇA

Adrenal hypoplasia, congenital

A disorder of adrenal gland development characterized by absence of the permanent zone of the adrenal cortex, structural disorganization of the adrenal glands, adrenal insufficiency and profound hormonal deficiencies. AHC patients manifest primary adrenal failure usually in early infancy, and hypogonadotropic hypogonadism leading to absent or incomplete sexual maturation. AHC can be inherited in an X-linked or autosomal recessive pattern.

EXPRESSÃO TECIDUAL(Tecido-específico)
Glândula adrenal
42.5 TPM
Testículo
39.1 TPM
Ovário
4.8 TPM
Pituitária
3.5 TPM
Cervix Ectocervix
2.9 TPM
OUTRAS DOENÇAS (5)
X-linked adrenal hypoplasia congenita46,XY sex reversal 246,XY complete gonadal dysgenesis46,XX testicular disorder of sex development
HGNC:7960UniProt:P51843
ATRXTranscriptional regulator ATRXDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (2)
Inhibition of DNA recombination at telomereDefective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations
MECANISMO DE DOENÇA

Alpha-thalassemia/impaired intellectual development syndrome, X-linked

A disorder characterized by severe psychomotor retardation, facial dysmorphism, urogenital abnormalities, and alpha-thalassemia. An essential phenotypic trait are hemoglobin H erythrocyte inclusions.

OUTRAS DOENÇAS (5)
intellectual disability-hypotonic facies syndrome, X-linked, 1alpha-thalassemia-myelodysplastic syndromealpha thalassemia-X-linked intellectual disability syndromegastric neuroendocrine neoplasm
HGNC:886UniProt:P46100
ARAndrogen receptorDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (6)
RUNX2 regulates osteoblast differentiationActivated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligandNuclear Receptor transcription pathwaySUMOylation of intracellular receptors
MECANISMO DE DOENÇA

Androgen insensitivity syndrome

An X-linked recessive form of pseudohermaphroditism due end-organ resistance to androgen. Affected males have female external genitalia, female breast development, blind vagina, absent uterus and female adnexa, and abdominal or inguinal testes, despite a normal 46,XY karyotype.

OUTRAS DOENÇAS (7)
Kennedy diseasehypospadias 1, X-linkedandrogen insensitivity syndromepartial androgen insensitivity syndrome
HGNC:644UniProt:P10275
CYP11A1Cholesterol side-chain cleavage enzyme, mitochondrialDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
Endogenous sterolsPregnenolone biosynthesis
MECANISMO DE DOENÇA

Adrenal insufficiency, congenital, with 46,XY sex reversal

A rare disorder that can present as acute adrenal insufficiency in infancy or childhood. ACTH and plasma renin activity are elevated and adrenal steroids are inappropriately low or absent; the 46,XY patients have female external genitalia, sometimes with clitoromegaly. The phenotypic spectrum ranges from prematurity, complete underandrogenization, and severe early-onset adrenal failure to term birth with clitoromegaly and later-onset adrenal failure. Patients with congenital adrenal insufficiency do not manifest the massive adrenal enlargement typical of congenital lipoid adrenal hyperplasia.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula adrenal
1056.4 TPM
Ovário
68.9 TPM
Testículo
47.5 TPM
Esôfago - Mucosa
8.1 TPM
Baço
6.5 TPM
OUTRAS DOENÇAS (2)
Congenital adrenal insufficiency with 46, XY sex reversal OR 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiencyinherited isolated adrenal insufficiency due to partial CYP11A1 deficiency
HGNC:2590UniProt:P05108
GATA4Transcription factor GATA-4Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (10)
Developmental Lineage of Pancreatic Acinar CellsDevelopmental Lineage of Multipotent Pancreatic Progenitor CellsDevelopmental Lineage of Pancreatic Ductal CellsSynthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)Cardiogenesis
MECANISMO DE DOENÇA

Atrial septal defect 2

A congenital heart malformation characterized by incomplete closure of the wall between the atria resulting in blood flow from the left to the right atria. Patients show other heart abnormalities including ventricular and atrioventricular septal defects, pulmonary valve thickening or insufficiency of the cardiac valves. The disease is not associated with defects in the cardiac conduction system or non-cardiac abnormalities.

EXPRESSÃO TECIDUAL(Tecido-específico)
Ovário
144.1 TPM
Coração - Átrio
53.7 TPM
Testículo
51.1 TPM
Coração - Ventrículo esquerdo
45.2 TPM
Artéria coronária
40.7 TPM
OUTRAS DOENÇAS (12)
tetralogy of fallotventricular septal defect 1testicular anomalies with or without congenital heart diseaseatrial septal defect 2
HGNC:4173UniProt:P43694
NR5A1Steroidogenic factor 1Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (4)
Transcriptional regulation of pluripotent stem cellsNuclear Receptor transcription pathwayTranscriptional regulation of testis differentiationSUMOylation of intracellular receptors
MECANISMO DE DOENÇA

46,XY sex reversal 3

A condition characterized by male-to-female sex reversal in the presence of a normal 46,XY karyotype.

EXPRESSÃO TECIDUAL(Tecido-específico)
Baço
221.6 TPM
Glândula adrenal
216.7 TPM
Ovário
74.6 TPM
Pituitária
33.4 TPM
Testículo
31.2 TPM
OUTRAS DOENÇAS (10)
spermatogenic failure 8premature ovarian failure 746,XX sex reversal 446,XY sex reversal 3
HGNC:7983UniProt:Q13285
DHHDesert hedgehog proteinDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (5)
Hedgehog 'on' stateActivation of SMOLigand-receptor interactionsRelease of Hh-Np from the secreting cellTranscriptional regulation of testis differentiation
MECANISMO DE DOENÇA

46,XY gonadal dysgenesis with minifascicular neuropathy

An autosomal recessive disorder characterized by gonadal dysgenesis associated with polyneuropathy. Genital anomalies include the presence of a testis on one side and a streak or an absent gonad at the other, persistence of Muellerian duct structures, and a variable degree of genital ambiguity.

EXPRESSÃO TECIDUAL(Tecido-específico)
Nervo tibial
58.0 TPM
Testículo
39.0 TPM
Artéria coronária
1.8 TPM
Rim - Medula
1.2 TPM
Tecido adiposo
1.2 TPM
OUTRAS DOENÇAS (3)
46,XY gonadal dysgenesis-motor and sensory neuropathy syndrome46,XY sex reversal 746,XY complete gonadal dysgenesis
HGNC:2865UniProt:O43323
SOX9Transcription factor SOX-9Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (7)
Deactivation of the beta-catenin transactivating complexTranscriptional regulation by RUNX2Transcriptional regulation of testis differentiationTranscriptional and post-translational regulation of MITF-M expression and activityDevelopmental Lineage of Multipotent Pancreatic Progenitor Cells
MECANISMO DE DOENÇA

Campomelic dysplasia

A rare, often lethal, osteochondrodysplasia characterized by congenital bowing and angulation of long bones. Other skeletal defects include unusually small scapula, deformed pelvis and spine, and a missing pair of ribs. Craniofacial and ear defects are common. Most patients die soon after birth due to respiratory distress which has been attributed to hypoplasia of the tracheobronchial cartilage and small thoracic cage. Up to two-thirds of affected XY individuals have genital defects or may develop as phenotypic females.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula salivar
110.7 TPM
Testículo
66.8 TPM
Brain Caudate basal ganglia
47.5 TPM
Cérebro - Amígdala
42.6 TPM
Córtex cerebral
42.6 TPM
OUTRAS DOENÇAS (8)
campomelic dysplasia46,XX sex reversal 246,XY sex reversal 1046,XY complete gonadal dysgenesis
HGNC:11204UniProt:P48436
ZFPM2Zinc finger protein ZFPM2Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (2)
Transcriptional regulation of testis differentiationFactors involved in megakaryocyte development and platelet production
MECANISMO DE DOENÇA

Tetralogy of Fallot

A congenital heart anomaly which consists of pulmonary stenosis, ventricular septal defect, dextroposition of the aorta (aorta is on the right side instead of the left) and hypertrophy of the right ventricle. In this condition, blood from both ventricles (oxygen-rich and oxygen-poor) is pumped into the body often causing cyanosis.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
39.2 TPM
Cerebelo
27.3 TPM
Ovário
27.0 TPM
Fallopian Tube
17.6 TPM
Útero
16.3 TPM
OUTRAS DOENÇAS (5)
tetralogy of fallot46,XY sex reversal 9diaphragmatic hernia 3congenital diaphragmatic hernia
HGNC:16700UniProt:Q8WW38
MAP3K1Mitogen-activated protein kinase kinase kinase 1Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (5)
FCERI mediated MAPK activationTRAF6 mediated NF-kB activationMyD88:MAL(TIRAP) cascade initiated on plasma membraneTRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activationMyD88 cascade initiated on plasma membrane
MECANISMO DE DOENÇA

46,XY sex reversal 6

A disorder of sex development. Affected individuals have a 46,XY karyotype but present as phenotypically normal females.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Not Sun Exposed Suprapubic
37.2 TPM
Skin Sun Exposed Lower leg
36.7 TPM
Tireoide
29.7 TPM
Baço
26.1 TPM
Vagina
21.2 TPM
OUTRAS DOENÇAS (3)
46,XY sex reversal 646,XY partial gonadal dysgenesis46,XY complete gonadal dysgenesis
HGNC:6848UniProt:Q13233
HSD17B317-beta-hydroxysteroid dehydrogenase type 3Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
Androgen biosynthesisSynthesis of very long-chain fatty acyl-CoAs
MECANISMO DE DOENÇA

Male pseudohermaphrodism with gynecomastia

An autosomal recessive disorder that manifests, in males, as undermasculinization characterized by hypoplastic-to-normal internal genitalia (epididymis, vas deferens, seminal vesicles, and ejaculatory ducts) but female external genitalia and the absence of a prostate. This phenotype is caused by inadequate testicular synthesis of testosterone, which, in turn, results in insufficient formation of dihydrotestosterone in the anlage of the external genitalia and prostate during fetal development. At the expected time of puberty, there is a marked increase in plasma leuteinizing hormone and, consequently, in testicular secretion of androstenedione. Hence, a diagnostic hallmark of this disorder is a decreased plasma testosterone-to-androstenedione ratio. Significant amounts of the circulating androstenedione are, however, converted to testosterone, in peripheral tissues, thereby causing virilization.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
41.3 TPM
Tireoide
13.9 TPM
Nervo tibial
13.8 TPM
Brain Spinal cord cervical c-1
8.4 TPM
Fígado
6.5 TPM
OUTRAS DOENÇAS (1)
46,XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency
HGNC:5212UniProt:P37058
HHATProtein-cysteine N-palmitoyltransferase HHATDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Hedgehog ligand biogenesis
MECANISMO DE DOENÇA

Nivelon-Nivelon-Mabille syndrome

An autosomal recessive syndrome characterized by progressive microcephaly, cerebellar vermis hypoplasia, and skeletal dysplasia. Additional variable features include early infantile-onset seizures, intrauterine and postnatal growth retardation, generalized chondrodysplasia, and micromelia. 46,XY gonadal dysgenesis may be present.

EXPRESSÃO TECIDUAL(Baixa expressão)
Tireoide
4.9 TPM
Glândula adrenal
4.8 TPM
Cervix Endocervix
4.4 TPM
Próstata
3.9 TPM
Glândula salivar
3.8 TPM
OUTRAS DOENÇAS (1)
chondrodysplasia-pseudohermaphroditism syndrome
HGNC:18270UniProt:Q5VTY9
RSPO1R-spondin-1Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Regulation of FZD by ubiquitination
MECANISMO DE DOENÇA

Keratoderma, palmoplantar, with squamous cell carcinoma of skin and sex reversal

A recessive syndrome characterized by XX (female to male) SRY-independent sex reversal, palmoplantar hyperkeratosis and predisposition to squamous cell carcinoma of the skin.

EXPRESSÃO TECIDUAL(Tecido-específico)
Útero
79.0 TPM
Cervix Endocervix
59.1 TPM
Cervix Ectocervix
52.6 TPM
Fallopian Tube
39.0 TPM
Vagina
27.4 TPM
OUTRAS DOENÇAS (1)
palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome
HGNC:21679UniProt:Q2MKA7
WT1Wilms tumor proteinDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (3)
Nephron developmentNegative Regulation of CDH1 Gene TranscriptionTranscriptional regulation of testis differentiation
MECANISMO DE DOENÇA

Frasier syndrome

Characterized by a slowly progressing nephropathy leading to renal failure in adolescence or early adulthood, male pseudohermaphroditism, and no Wilms tumor. As for histological findings of the kidneys, focal glomerular sclerosis is often observed. There is phenotypic overlap with Denys-Drash syndrome. Inheritance is autosomal dominant.

EXPRESSÃO TECIDUAL(Tecido-específico)
Útero
109.7 TPM
Fallopian Tube
75.2 TPM
Ovário
65.2 TPM
Testículo
40.5 TPM
Adipose Visceral Omentum
30.0 TPM
OUTRAS DOENÇAS (12)
Wilms tumor 1nephrotic syndrome, type 4Meacham syndromemalignant mesothelioma
HGNC:12796UniProt:P19544
TSPYL1Testis-specific Y-encoded-like protein 1Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Sudden infant death with dysgenesis of the testes syndrome

Autosomal recessive disorder. Affected infants appear normal at birth, develop signs of visceroautonomic dysfunction early in life, and die before 12 months of age of abrupt cardiorespiratory arrest. Features included bradycardia, hypothermia, severe gastroesophageal reflux, laryngospasm, bronchospasm, and abnormal cardiorespiratory patterns during sleep. Genotypic males with SIDDT had fetal testicular dysgenesis and ambiguous genitalia, with findings such as intraabdominal testes, dysplastic testes, deficient fetal testosterone production, fusion and rugation of the gonadal sac, and partial development of the penile shaft. Female sexual development was normal. Affected infants had an unusual staccato cry, similar to the cry of a goat.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
243.9 TPM
Brain Frontal Cortex BA9
224.4 TPM
Cerebelo
170.5 TPM
Brain Nucleus accumbens basal ganglia
136.9 TPM
Córtex cerebral
129.7 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (1)
sudden infant death-dysgenesis of the testes syndrome
HGNC:12382UniProt:Q9H0U9
AMHAnti-Muellerian hormoneDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
Signaling by BMPTranscriptional regulation of testis differentiation
MECANISMO DE DOENÇA

Persistent Muellerian duct syndrome 1

A form of male pseudohermaphroditism characterized by a failure of Muellerian duct regression in otherwise normal males.

OUTRAS DOENÇAS (1)
persistent Mullerian duct syndrome
HGNC:464UniProt:P03971

Medicamentos e terapias

TESTOSTERONEPhase 4

Mecanismo: Androgen Receptor agonist

TESTOSTERONE UNDECANOATEPhase 4

Mecanismo: Androgen Receptor agonist

SOMATROPINPhase 4

Mecanismo: Growth hormone receptor agonist

GONADOTROPIN, CHORIONICPhase 3

Mecanismo: Luteinizing hormone/Choriogonadotropin receptor agonist

ANASTROZOLEPhase 3

Mecanismo: Cytochrome P450 19A1 inhibitor

SEMAGLUTIDEPhase 3

Mecanismo: Glucagon-like peptide 1 receptor agonist

ESTROGENS, CONJUGATEDPhase 3

Mecanismo: Estrogen receptor agonist

ESTRADIOLPhase 3

Mecanismo: Estrogen receptor alpha agonist

ETHINYL ESTRADIOLPhase 3

Mecanismo: Estrogen receptor alpha agonist

OXANDROLONEPhase 3

Mecanismo: Androgen Receptor agonist

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

556 variantes patogênicas registradas no ClinVar.

🧬 SRD5A2: NM_000348.4(SRD5A2):c.453del (p.Leu152fs) ()
🧬 SRD5A2: NM_000348.4(SRD5A2):c.354C>G (p.Phe118Leu) ()
🧬 SRD5A2: NM_000348.4(SRD5A2):c.445+1G>A ()
🧬 SRD5A2: NM_000348.4(SRD5A2):c.554T>A (p.Leu185Ter) ()
🧬 SRD5A2: NM_000348.4(SRD5A2):c.269A>G (p.His90Arg) ()
Ver todas no ClinVar

Vias biológicas (Reactome)

87 vias biológicas associadas aos genes desta condição.

Androgen biosynthesis rRNA modification in the nucleus and cytosol Major pathway of rRNA processing in the nucleolus and cytosol Nuclear signaling by ERBB4 Negative regulation of activity of TFAP2 (AP-2) family transcription factors Activation of the TFAP2 (AP-2) family of transcription factors Deactivation of the beta-catenin transactivating complex trans-Golgi Network Vesicle Budding Lysosome Vesicle Biogenesis Golgi Associated Vesicle Biogenesis Cargo recognition for clathrin-mediated endocytosis Clathrin-mediated endocytosis Interleukin-12 signaling Synthesis of PIPs at the plasma membrane Synthesis of PIPs at the early endosome membrane Synthesis of PIPs at the late endosome membrane Pre-NOTCH Transcription and Translation Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells NOTCH1 Intracellular Domain Regulates Transcription NOTCH2 intracellular domain regulates transcription Constitutive Signaling by NOTCH1 PEST Domain Mutants Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants Notch-HLH transcription pathway RUNX3 regulates NOTCH signaling NOTCH3 Intracellular Domain Regulates Transcription NOTCH4 Intracellular Domain Regulates Transcription Formation of paraxial mesoderm PIP3 activates AKT signaling Constitutive Signaling by Aberrant PI3K in Cancer PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling MECP2 regulates transcription of neuronal ligands BDNF activates NTRK2 (TRKB) signaling Activated NTRK2 signals through RAS Activated NTRK2 signals through PLCG1 Activated NTRK2 signals through PI3K Activated NTRK2 signals through FRS2 and FRS3 Activated NTRK2 signals through FYN NTRK2 activates RAC1 Activated NTRK2 signals through CDK5 NPAS4 regulates expression of target genes Regulation of gene expression in beta cells Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) Activation of anterior HOX genes in hindbrain development during early embryogenesis Formation of the anterior neural plate Transcriptional regulation of testis differentiation Signaling by BMP Nuclear Receptor transcription pathway Inhibition of DNA recombination at telomere Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand SUMOylation of intracellular receptors Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 Ub-specific processing proteases RUNX2 regulates osteoblast differentiation Pregnenolone biosynthesis Endogenous sterols Defective CYP11A1 causes AICSR YAP1- and WWTR1 (TAZ)-stimulated gene expression Physiological factors Cardiogenesis Formation of lateral plate mesoderm Formation of definitive endoderm Factors involved in megakaryocyte development and platelet production Developmental Lineage of Pancreatic Acinar Cells Developmental Lineage of Pancreatic Ductal Cells Developmental Lineage of Multipotent Pancreatic Progenitor Cells Transcriptional regulation of pluripotent stem cells Class B/2 (Secretin family receptors) Hedgehog ligand biogenesis Release of Hh-Np from the secreting cell Ligand-receptor interactions Hedgehog 'on' state Activation of SMO HHAT G278V doesn't palmitoylate Hh-Np Transcriptional regulation by RUNX2 Transcriptional and post-translational regulation of MITF-M expression and activity MyD88:MAL(TIRAP) cascade initiated on plasma membrane FCERI mediated MAPK activation TRAF6 mediated NF-kB activation TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation MyD88 cascade initiated on plasma membrane Synthesis of very long-chain fatty acyl-CoAs Regulation of FZD by ubiquitination Negative Regulation of CDH1 Gene Transcription Nephron development

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
✓Aprovado3
3Fase 310
2Fase 23
1Fase 12
·Pré-clínico22
Medicamentos catalogadosEnsaios clínicos· 10 medicamentos · 30 ensaios
✓ Aprovados — podem ser usados hoje
TESTOSTERONETESTOSTERONE UNDECANOATESOMATROPIN
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Doença do desenvolvimento sexual

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Onde estão os ensaios

Com ensaio aberto em 3 países. O ponto verde marca onde há vaga agora.

🟢 Recrutando agora

6 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

30 ensaios clínicos encontrados, 6 ativos.

Distribuição por fase
NCT06687252 · Retrospective Analysis of the Neonatal Management of Patient…Concluído
🇫🇷 França
NCT06682078 · Disorders of Sexual Development and Gonadal Tumor RiskConcluído
🇫🇷 França
NCT05449080 · Disorders of Sex Development (DSD) 46.XY in Three SiblingsConcluído
Indonesia
NCT05640960 · Undifferentiated Embryonal Sarcoma of the Liver: Evaluation …Concluído
🇫🇷 França
NCT03898440 · Fetal Ano-genital Distance in 2D Ultrasound.Concluído
🇫🇷 França
NCT03718234 · Subcutaneous Hydrocortisone Children With Congenital Adrenal…Concluído
PHASE1🇺🇸 Estados Unidos
NCT03028545 · Representations and Strategies for RecoveryConcluído
NA🇫🇷 França
NCT02605967 · Safety and Efficacy Study of PDR001 in Patients With Recurre…Concluído
PHASE2🇨🇳 China · 🇫🇷 França · Hong Kong +4
NCT01875640 · Decision Support for Parents Receiving Information About Chi…Concluído
🇺🇸 Estados Unidos
NCT01190267 · Flexible Dose, Long-term Safety Study of Asenapine for the T…Concluído
PHASE3
NCT01190254 · Fixed Dose Efficacy and Safety Study of Asenapine for the Tr…Concluído
PHASE3
NCT00559078 · Qualitative Research on Women With Congenital Adrenal Hyperp…Concluído
🇺🇸 Estados Unidos
NCT04831099 · Testosterone Treatment in a Patient With 17β-hydroxysteroid …UNKNOWN
PHASE3🇳🇱 Países Baixos
NCT04195490 · Evaluation of Outcomes of Feminizing Genitoplasty in Childre…UNKNOWN
NA
NCT02784184 · COPENHAGEN Minipuberty StudyUNKNOWN
🇩🇰 Dinamarca
NCT04028297 · Focus Cardiac Ultrasound in Patients With ShockUNKNOWN
🇫🇷 França
NCT00173654 · Mutation Analysis of 17βhydroxysteroid Dehydrogenase 3 Defic…UNKNOWN
🇹🇼 Taiwan
NCT00172510 · Mutation Analysis of 17α-HydroxylaseUNKNOWN
🇹🇼 Taiwan
NCT04315883 · Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Ad…Encerrado
🇺🇸 Estados Unidos
NCT02012192 · GANNET53: Ganetespib in Metastatic, p53-mutant, Platinum-res…Encerrado
PHASE1, PHASE2🇦🇹 Áustria · 🇧🇪 Bélgica · 🇫🇷 França +1
NCT01204788 · Prophylactic White Cell Transfusions Versus Therapeutic Whit…Encerrado
PHASE2🇺🇸 Estados Unidos
NCT02349503 · Safety, Pharmacokinetics and Pharmacodynamics of NBI-77860 i…Cancelado
PHASE1🇺🇸 Estados Unidos
NCT01011400 · Ultrasonic Measurements of the Clitoris in FetusesCancelado
🇮🇱 Israel
NCT00485186 · Gene Polymorphisms Influencing Steroid Synthesis and ActionCancelado
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
80 papers (10 anos)
#1

Sexual functioning, mental health and quality of life in 46,XX male: a case report.

Journal of medical case reports2026 Feb 28

The 46,XX testicular difference of sex development is a rare genetic condition linked to primary hypogonadism and male infertility. However, research on how this condition affects male sexual functioning is lacking. Here, we describe the several dimensions of sexual function and its related associates in a 27-year-old Egyptian male man who has the disease but did not initially disclose any sexual dysfunction. Using self-administered validated questionnaires, the man demonstrated a reduction in erectile function, sexual desire, and intercourse satisfaction, along with premature ejaculation. Additionally, he had varying degrees of mental disorders, including depression, anxiety, and perceived stress. The hormonal assay revealed hypergonadotropic hypogonadism. The quality of life was poor. To the best of our knowledge, this is the first case report that used validated measuring instruments to show detrimental alterations in mood, numerous facets of sexual function, and quality of life in a man with 46,XX testicular difference of sex development. Men with this syndrome should receive a multidisciplinary strategy, which includes coping with hypogonadism and psychological support, in addition to sexual dysfunction treatment. This can help patients enhance their quality of life.

#2

From Primary Amenorrhea to the Desert Hedgehog Gene: Novel Homozygous Variant in 46,XY Gonadal Dysgenesis.

Journal of pediatric and adolescent gynecology2026 Feb 08

46,XY gonadal dysgenesis is a rare difference of sex development in which individuals have female external genitalia despite a 46,XY karyotype. Pathogenic variants in genes involved in testis determination and differentiation may underlie the condition and should be considered in the evaluation of primary amenorrhea. A 14-year-old girl presented with primary amenorrhea. Hormonal evaluation revealed hypergonadotropic hypogonadism, and imaging demonstrated absence of the uterus and ovaries. Gonadectomy specimens demonstrated testicular tissue. Genetic analysis identified a novel homozygous missense likely pathogenic variant in the Desert Hedgehog (DHH) gene (NM_021044.4:c.983T>C; p.Leu328Pro). The DHH gene plays a critical role in testis differentiation, and pathogenic variants may result in 46,XY gonadal dysgenesis. Hormone replacement therapy and long-term multidisciplinary follow-up are essential components of management.

#3

[Association between Y chromosome microdeletions and tes-ticular development in male pediatric patients with congenital reproductive system diseases].

Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences2025 Dec 25

To analyze the distribution of Y chromosome azoospermia factor (AZF) microdeletions and their association with testicular development in male pediatric patients with congenital reproductive system diseases. A prospective cohort study was conducted on pediatric patients admitted to the Department of Urology of Shanghai Children's Hospital from November 2021 to December 2023. The observation group included boys with hypospadias, cryptorchidism, or disorders of sex development (DSD), while the control group comprised boys with phimosis, indirect inguinal hernia, or hydrocele. Blood samples were collected for AZF microdeletion analysis using multiplex PCR to detect 15 sequence-tagged sites. Testicular ultrasound was performed to record testicular position and volume. Propensity score matching (PSM) was used to balance the groups. After matching, testicular volume differences were assessed. Stratified analyses compared testicular volume among children with AZF microdeletions, the control group, and children without AZF microdeletions in the observation group. A total of 493 children were enrolled (observation group: 463; control group: 30). The observation group consisted of 372 cases of hypospadias, 71 cases of cryptorchidism, and 20 cases of DSD. No Y chromosome microdeletions were detected in the control group. Four boys in the observation group had AZF microdeletions: one with cryptorchidism (AZFc+AZFd), one with isolated hypospadias (AZFc), and two with DSD (one with AZFb+AZFc+AZFd and one with AZFa). Ultraso-nography was performed for 888 testes. After PSM, testicular volume was significantly smaller in the observation group than that in the control group (P<0.01). Stratified analysis revealed a trend towards smaller testicular volumes in children with AZF microdeletions compared to the other two groups. The prevalence of Y chromosome microdeletions is higher in male children with congenital reproductive system diseases compared to the general population, particularly in those with DSD. Hypospadias, cryptorchidism, DSD, and AZF microdeletions may be associated with delayed testicular development in these children. 目的: 分析先天性生殖系统疾病男性患儿Y染色体无精子症因子(AZF)微缺失的分布及对睾丸发育的影响。方法: 前瞻性队列研究分析2021年11月至2023年12月上海交通大学医学院附属儿童医院泌尿外科收治的手术患儿,观察组为尿道下裂、隐睾、性发育异常患儿,对照组为包茎、腹股沟斜疝或鞘膜积液患儿。收集患儿的血液标本,采用多重聚合酶链反应法对Y染色体AZF的15个位点进行检测。同时对观察组和对照组进行睾丸超声检查,记录睾丸位置及睾丸体积。经倾向评分匹配(PSM)和按照患儿年龄进行分层后,分析对照组与观察组间以及有无AZF微缺失患儿间睾丸体积的差异。结果: 入组患儿共493例,其中观察组463例(尿道下裂372例,隐睾71例,性发育异常20例),对照组30例。对照组中未发现Y染色体微缺失病例,观察组中有4例患儿出现Y染色体微缺失,其中隐睾患儿1例(AZFc+AZFd区),孤立性尿道下裂患儿1例(AZFc区),性发育异常患儿2例(分别为AZFb+AZFc+AZFd区和AZFa区)。超声下测量睾丸888侧,PSM后对照组患儿的睾丸体积大于观察组(P<0.01)。分层分析结果显示,观察组有AZF微缺失患儿的睾丸体积有小于对照组和观察组无AZF微缺失患儿的趋势。结论: 先天性生殖系统疾病男性患儿出现Y染色体AZF微缺失的概率大于普通人群,其中性发育异常患儿出现Y染色体AZF微缺失的概率大于隐睾及尿道下裂患儿。尿道下裂、隐睾和性发育异常及AZF微缺失均可能延缓患儿的睾丸发育。.

#4

Neurocognitive function in males with 46,XX testicular difference of sex development.

Orphanet journal of rare diseases2025 Nov 25

46,XX testicular difference of sex development (46,XX T-DSD) is a rare condition, in which individuals with a typical female chromosomal pattern (46,XX) present with a male phenotype. Although neurocognitive function has previously been reported as normal in males with 46,XX T-DSD, studies indicate potential neurocognitive challenges, including lower educational attainment. We aimed to assess neurocognitive function in males with 46,XX T-DSD compared to 46,XY male controls using the Wechsler Adult Intelligence Scale, Fourth Edition (WAIS-IV). 47 participants were included in the study, comprising 25 males with 46,XX T-DSD and 22 46,XY male controls matched on age and educational level. Of the 25 46,XX T-DSD males, 23 had an SRY translocation, while the remaining two were SRY-negative; one of these showed a SOX9 duplication, and no genetic cause was identified for the other despite extensive testing. All participants completed the WAIS-IV. We calculated each participant's Full-Scale Intelligence Quotient (FSIQ) and four index scores: Verbal Comprehension Index, Perceptual Reasoning Index, Working Memory Index, and Processing Speed Index. Males with 46,XX T-DSD scored significantly lower on the Working Memory Index (mean ± SD: 93.3 ± 15.7 vs. 104.3 ± 14.6, p = 0.017) compared to controls, with two of three subtests showing lower scores (p < 0.05). In the 46,XX T-DSD group, mean scores on the Verbal Comprehension Index and overall FSIQ were 91.6 ± 16.7 and 93.8 ± 15.6, respectively, compared with 98.9 ± 11.4 and 100.7 ± 10.3 in controls. Neither difference reached statistical significance (VCI: p = 0.092, FSIQ: p = 0.086). All mean scores for both groups remained within the normal range. Among males with 46,XX T-DSD, 56% (n = 14) scored in the low average range (80-89) or below on the FSIQ, compared to only 13.6% (n = 3) in the control group. Additionally, two males in the 46,XX T-DSD group scored in the extremely low range (≤ 69), whereas none in the control group did. Our findings indicate that 46,XX T-DSD males score significantly lower on the Working Memory Index compared to controls. No other statistically significant differences in index scores were observed, and all mean scores for both groups remained within the normal range. Larger-scale research and more comprehensive assessments of non-cognitive factors will be essential for gaining deeper insight into these findings and assessing their clinical significance.

#5

Persistent Müllerian duct syndrome - a rare but important cause of male factor infertility.

Nature reviews. Urology2025 Nov 07

Persistent Müllerian duct syndrome (PMDS) is a rare difference of sex development, characterized by the presence of Müllerian duct derivatives in 46,XY individuals with male-typical development. PMDS typically presents during childhood with features of cryptorchidism, inguinal hernia or transverse testicular ectopia. Untreated PMDS is associated with risks of infertility and malignancy. Infertility is common, arising from cryptorchidism, anatomical malformations (such as epididymal aplasia) or extrinsic compression of the ejaculatory duct by Müllerian structures. At the time of diagnosis, just one in five men with PMDS are reported to have conceived naturally. Preservation of fertility potential requires prompt diagnosis and management via a holistic patient-centred approach that addresses the underlying cause. With cryptorchidism, which is a common manifestation of PMDS, early orchidopexy is the key initial intervention. The input of fertility specialists and assisted reproductive techniques can further support successful conception. Beyond its effects on fertility, PMDS carries a risk of malignant transformation in the testes and Müllerian structures, warranting complex management with inclusion of a multi-disciplinary team and consideration of orchidopexy, orchidectomy, excision of Müllerian remnants and onward surveillance. Thus, although rare, PMDS is an important cause of male factor infertility that might be encountered by urologists. Preservation of fertility potential requires a high index of clinical suspicion and timely intervention. Raising awareness of PMDS among clinicians is crucial to improve its detection, advance its clinical management and provide a basis for future research.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC29 artigos no totalmostrando 77

2026

Sexual functioning, mental health and quality of life in 46,XX male: a case report.

Journal of medical case reports
2026

From Primary Amenorrhea to the Desert Hedgehog Gene: Novel Homozygous Variant in 46,XY Gonadal Dysgenesis.

Journal of pediatric and adolescent gynecology
2025

Case Report: Challenges of an extremely delayed diagnosis of classic congenital adrenal hyperplasia in a completely virilized 46,XX patient.

Frontiers in endocrinology
2025

[Association between Y chromosome microdeletions and tes-ticular development in male pediatric patients with congenital reproductive system diseases].

Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences
2025

Neurocognitive function in males with 46,XX testicular difference of sex development.

Orphanet journal of rare diseases
2025

Persistent Müllerian duct syndrome - a rare but important cause of male factor infertility.

Nature reviews. Urology
2025

Outcomes of pregnancies that screened positive for sex chromosome aneuploidy ascertained via cell-free DNA screening.

Journal of genetic counseling
2025

Differences in sex development: Taking inventory of function and anatomy to empower self care.

Seminars in pediatric surgery
2025

Strategies for improving the knowledge of patients and carers.

Best practice &amp; research. Clinical endocrinology &amp; metabolism
2025

Gonadectomy in individuals with a difference of sex development - For whom, when, why, and why not?

Best practice &amp; research. Clinical endocrinology &amp; metabolism
2025

An Unusual and Late Presentation of 46, XY Ovotesticular Difference of Sex Development.

JCEM case reports
2025

Androgen insensitivity and the evolving genetic heterogeneity.

Best practice &amp; research. Clinical endocrinology &amp; metabolism
2025

Who may compete in the female category in sport? Chromosomes, genes, hormones, and psychosocial/cultural aspects.

Current opinion in pediatrics
2025

Can Individuals with 47,XYY Karyotypes Exist without Male Phenotype? A Narrative Literature Review and Case Report.

Frontiers in bioscience (Scholar edition)
2025

Practice patterns in the care of proximal hypospadias among pediatric urologists.

Journal of pediatric urology
2025

Guidance for shared decision-making regarding orchiectomy in individuals with differences of sex development due to 17-β-hydroxysteroid dehydrogenase type 3 deficiency.

Frontiers in pediatrics
2025

Satisfaction with health care among people with differences of sex development (DSD) in Germany.

Endocrine connections
2025

Prevalence of Psychiatric Comorbidities in Females With Classic Congenital Adrenal Hyperplasia.

The Journal of clinical endocrinology and metabolism
2024

Integration of long-read sequencing, DNA methylation and gene expression reveals heterogeneity in Y chromosome segment lengths in phenotypic males with 46,XX testicular disorder/difference of sex development.

Biology of sex differences
2024

A Case Report on 46,XX Male Difference of Sex Development.

Cureus
2024

Genome-wide methylation analysis in patients with proximal hypospadias - a pilot study and review of the literature.

Epigenetics
2024

A multicenter analysis of individuals with a 47,XXY/46,XX karyotype.

Genetics in medicine : official journal of the American College of Medical Genetics
2024

LINE1-mediated epigenetic repression of androgen receptor transcription causes androgen insensitivity syndrome.

Scientific reports
2024

Mixed Gonadal Dysgenesis: A Narrative Literature Review and Clinical Primer for the Urologist.

The Journal of urology
2024

Digenic Origin of Difference of Sex Development in a Patient Harbouring DHX37 and MAMLD1 Variants.

Case reports in pediatrics
2024

Issues in Distinguishing Sex and Gender in Surgical Registries: NSQIP and VASQIP Analysis.

Journal of the American College of Surgeons
2024

Trajectories of illness uncertainty among parents of children with atypical genital appearance due to differences of sex development.

Journal of pediatric psychology
2023

Contexts of care for people with differences of sex development: Diversity is still missing in the laboratory routine.

Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V
2024

Endometriosis in a Prepubertal Patient with 46,XY Difference in Sex Development: A Case Report.

Journal of pediatric and adolescent gynecology
2024

Ovotesticular cords and ovotesticular follicles: New histologic markers for human ovotesticular syndrome.

Journal of pediatric urology
2024

For the penile length-how shall we choose the straightening procedures in hypospadias repair?

Andrology
2024

Spleen function is reduced in individuals with NR5A1 variants with or without a difference of sex development: a cross-sectional study.

European journal of endocrinology
2024

Working towards convergence of the clinical management of differences of sex development/intersex conditions and the human rights framework: A case study.

Clinical endocrinology
2023

Comparison of web-based information about cell-free DNA prenatal screening: implications for differences of sex development care.

Frontiers in urology
2023

A Novel Variant in NR5A1 Presenting as 46,XY Difference of Sex Development.

JCEM case reports
2023

Genetic reanalysis of patients with a difference of sex development carrying the NR5A1/SF-1 variant p.Gly146Ala has discovered other likely disease-causing variations.

PloS one
2023

"It became easier once I knew": Stakeholder perspectives for educating children and teenagers about their difference of sex development.

Patient education and counseling
2022

Case Report: De novo variant in myelin regulatory factor in a Chinese child with 46,XY disorder/difference of sex development, cardiac and urogenital anomalies, and short stature.

Frontiers in pediatrics
2023

FGF9 variant in 46,XY DSD patient suggests a role for dimerization in sex determination.

Clinical genetics
2023

A survey of healthcare professionals' perceptions of the decisional needs of parents with an infant born with a disorder/difference of sex development.

Journal of pediatric urology
2022

Diagnosis of DSD in Children-Development of New Tools for a Structured Diagnostic and Information Management Program within the Empower-DSD Study.

Journal of clinical medicine
2022

Primary Amenorrhea and Differences of Sex Development.

Seminars in reproductive medicine
2022

So, and if it is not congenital adrenal hyperplasia? Addressing an undiagnosed case of genital ambiguity.

Italian journal of pediatrics
2022

A Novel Compound Heterozygous Mutation of HSD17B3 Gene Identified in a Patient With 46,XY Difference of Sexual Development.

Sexual medicine
2022

Stigma, Intrusiveness, and Distress in Parents of Children with a Disorder/Difference of Sex Development.

Journal of developmental and behavioral pediatrics : JDBP
2022

46 XY undervirulized male DSD: Reporting a patient with prenatally diagnosed disorder/difference of sex development (DSD) with heterozygous LHCGR mutations.

Urology case reports
2022

Update on the management of a newborn with a suspected difference of sex development.

Archives of disease in childhood
2022

The Desert Hedgehog Signalling Pathway in Human Gonadal Development and Differences of Sex Development.

Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation
2022

A Small Supernumerary Xp Marker Chromosome Including Genes NR0B1 and MAGEB Causing Partial Gonadal Dysgenesis and Gonadoblastoma.

Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation
2023

Ovotesticular Difference of Sex Development: Genetic Background, Histological Features, and Clinical Management.

Hormone research in paediatrics
2021

Behavioral Health Diagnoses in Youth with Differences of Sex Development or Congenital Adrenal Hyperplasia Compared with Controls: A PEDSnet Study.

The Journal of pediatrics
2022

The radiologist's role in assessing differences of sex development.

Pediatric radiology
2021

Generation of two human induced pluripotent stem cell lines from a patient with complete androgen insensitivity syndrome with a hemizygous single nucleotide variant in the androgen receptor (AR) gene.

Stem cell research
2021

A case of late diagnosis and management of 46 XY complete gonadal dysgenesis in adulthood.

Ginekologia polska
2020

Parent experience with volunteers and support groups in a multidisciplinary DSD clinic.

Clinical practice in pediatric psychology
2021

Social media engagement, perpetuating selected information, and accuracy regarding CA SB-201: Treatment or intervention on the sex characteristics of a minor.

Journal of pediatric urology
2021

Distress Trajectories for Parents of Children With DSD: A Growth Mixture Model.

Journal of pediatric psychology
2021

Approach to the Virilizing Girl at Puberty.

The Journal of clinical endocrinology and metabolism
2020

Variants of STAR, AMH and ZFPM2/FOG2 May Contribute towards the Broad Phenotype Observed in 46,XY DSD Patients with Heterozygous Variants of NR5A1.

International journal of molecular sciences
2021

A local criterion of fairness in sport: Comparing the property advantages of Caster Semenya and Eero Mäntyranta with implications for the construction of categories in sport.

Bioethics
2020

Gender identity: A psychosocial primer for providing care to patients with a disorder/difference of sex development and their families [individualized care for patients with intersex (Disorders/differences of sex development): Part 2].

Journal of pediatric urology
2020

Puberty in Patients with Ovotesticular DSD: Evaluation of 20 Patients and Review of the Literature.

Pediatric endocrinology reviews : PER
2020

A Case of 45,X/46,XY Mosaicism Presenting as Swyer Syndrome.

Journal of pediatric and adolescent gynecology
2019

Cytogenetic Spectrum of Ovotesticular Difference of Sex Development (OT DSD) among a Large Cohort of DSD Patients and Literature Review.

Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation
2020

Community perspectives on difference of sex development (DSD) diagnoses: A crowdsourced survey.

Journal of pediatric urology
2019

Breast development and satisfaction in women with disorders/differences of sex development.

Human reproduction (Oxford, England)
2019

Standardised data collection for clinical follow-up and assessment of outcomes in differences of sex development (DSD): recommendations from the COST action DSDnet.

European journal of endocrinology
2019

Yield of modern genetic evaluation for patients with proximal hypospadias and descended gonads.

Journal of pediatric urology
2019

Functional Characterization of Two New Variants in the Bone Morphogenetic Protein 7 Prodomain in Two Pairs of Monozygotic Twins With Hypospadias.

Journal of the Endocrine Society
2019

Laparoscopic Bilateral Gonadectomy and Inguinal Hernia Repair with Mesh for Complete Androgen Insensitivity Syndrome: A Case Report.

Journal of pediatric and adolescent gynecology
2018

Psychosocial Screening in Disorders/Differences of Sex Development: Psychometric Evaluation of the Psychosocial Assessment Tool.

Hormone research in paediatrics
2018

Evaluation of DSD training schools organized by cost action BM1303 "DSDnet".

Orphanet journal of rare diseases
2018

Caring for individuals with a difference of sex development (DSD): a Consensus Statement.

Nature reviews. Endocrinology
2018

Sexual and gender minority health in medical curricula in new England: a pilot study of medical student comfort, competence and perception of curricula.

Medical education online
2018

Improving Laboratory Assessment in Disorders of Sex Development through a Multidisciplinary Network.

Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation
2017

Attitudes towards "disorders of sex development" nomenclature among affected individuals.

Journal of pediatric urology
2017

A practical guide for evaluating gonadal germ cell tumor predisposition in differences of sex development.

American journal of medical genetics. Part C, Seminars in medical genetics

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Doença do desenvolvimento sexual.

É de uma associação que acompanha esta doença? Fale com a gente →

Doença com base genética

Um médico geneticista pode ajudar no diagnóstico de Doença do desenvolvimento sexual e no aconselhamento genético da família.

Vai consultar um especialista? Confirme o registro dele no conselho.
Conselhos e sociedades

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Perguntas frequentes

O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu

Respostas geradas por IA a partir das fontes citadas

É uma condição presente desde o nascimento na qual o desenvolvimento das características sexuais biológicas ocorre de maneira diferente do habitual. Ela engloba um grupo amplo de situações clínicas classificadas sob o código internacional ORPHA:90771.

Referências

Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete

8 publicações do grafo RarasNet (PubMed) · 6 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.

  1. ORPHA:90771
    Orphanet
  2. Q5282521
    Wikidata

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Citar este verbete

Raras. (s.d.). Doença do desenvolvimento sexual. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/doenca-do-desenvolvimento-sexual

Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Doença do desenvolvimento sexual

ORPHA:90771 · MONDO:0002145
Ensaios
6 ativos
Medicamentos
14 registrados
MedGen
UMLS
C0036875
EuropePMC
Wikidata
Wikipedia
Papers 10a

📋 Origem dos dados

Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.

Doença rara (ontologia)
fonte: Orphanet
Identificador unificado
fonte: MONDO
Indexação biomédica
fonte: MeSH (NLM)
Dado público estruturado
fonte: Wikidata
Moléculas estudadas na doença
fonte: OpenTargets
Rara